Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Top US court rejects Pfizer appeal and allows Nigerians to proceed with Trovan claims

This article was originally published in SRA

Executive Summary

The US Supreme Court has declined to hear an appeal by Pfizer for review of a 2009 federal appeals court ruling that reinstated claims in US lawsuits by Nigerian families relating to the company's use of its antibiotic Trovan (trovafloxacin mesylate) in children during a meningitis epidemic1,2. The lawsuits claimed that the company, working in concert with Nigerian government officials, tested Trovan in children without obtaining informed consent, and failed to disclose the experimental nature of the study or the serious risks involved.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS115398

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel